ROSSMAX AUTOMATIC WRISTWATCH BLOOD PRESSURE MONITOR, MODEL Z44

K993426 · Rossmax International , Ltd. · DXN · Jan 7, 2000 · Cardiovascular

Device Facts

Record IDK993426
Device NameROSSMAX AUTOMATIC WRISTWATCH BLOOD PRESSURE MONITOR, MODEL Z44
ApplicantRossmax International , Ltd.
Product CodeDXN · Cardiovascular
Decision DateJan 7, 2000
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1130
Device ClassClass 2

Intended Use

To measure systolic and diastolic blood pressure and heart rate on the wrist using the oscillometric method. Limited to patient over 18 years and wrist circumference between 5.3 to 7.7 inches.

Device Story

Automatic wristwatch blood pressure monitor; uses oscillometric method to measure systolic/diastolic blood pressure and heart rate; intended for over-the-counter use by adults; device worn on wrist; provides digital readout of blood pressure and pulse; assists users in monitoring cardiovascular health at home.

Clinical Evidence

No clinical data provided in the document; substantial equivalence determination based on 510(k) submission review.

Technological Characteristics

Wrist-worn oscillometric blood pressure monitor; measures systolic/diastolic pressure and heart rate; designed for adult wrist circumferences 5.3 to 7.7 inches.

Indications for Use

Indicated for adults over 18 years with wrist circumference 5.3 to 7.7 inches for measurement of systolic/diastolic blood pressure and heart rate.

Regulatory Classification

Identification

A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Image /page/0/Picture/2 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo consists of a circular arrangement of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around a central graphic. The graphic features a stylized representation of a human figure, with three overlapping profiles suggesting a sense of community or interconnectedness. The overall design is simple and conveys a sense of unity and purpose. ## JAN - 7 2000 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Michael Yeh Managing Director Rossmax International Ltd. 5F., No. 6, Alley 20, Lane 106 Section 3, Nan Kang Road Taipei, Taiwan Re: K993426 Rossmax Automatic Wristwatch Blood Pressure Monitors Requlatory Class: II (two) Product Code: DXN December 13, 1999 Dated: Received: December 15, 1999 Dear Mr. Yeh: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {1}------------------------------------------------ Page 2 - Mr. Michael Yeh This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, State L. Imperiale Celia M. Witten, Ph.D., M.D. Acting Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## ATTACHMENT 1 ## Indications for Use Statement | Device Names: | Rossmax Automatic Wristwatch Blood Pressure Monitor, model<br>Z44 | |----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indications For Use: | To measure systolic and diastolic blood pressure and heart rate on<br>the wrist using the oscillometric method. Limited to patient over<br>18 years and wrist circumference between 5.3 to 7.7 inches. | Concurrence of CDRH, Office of Device Evaluation (ODE) Bera Lemperle (Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number________________________________________________________________________________________________________________________________________ Prescription Use______________________________________________________________________________________________________________________________________________________________ or Over-the-counter use_X
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from the tree

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...